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The dihydrofolate reductase (DHFR) domain of P. falciparum is one of the few well defined targets in malarial chemotherapy. The enzyme catalyzes the 
nicotinamide adenine dinucleotide phosphate (NADPH) dependent reduction of dihydrofolate to tetrahydrofolate. Protein-ligand interactions were studied using 
DHFR protein 2BL9, extracted from PDB to evaluate the strength of affinity of various molecules towards ligand binding site and to study the extent of correlation 
between experimental values and computational dock scores. AutoDock runs resulted in binding energy scores from -7.14 to -10.72 kcal/mol. Among the five 
inhibitors (Bioorganic and Medicinal Chemistry Letters 15 2005 531-533) selected for docking studies, an excellent correlation was observed in all cases, for 
instance, experimentally reported most active molecule 2a (MIC: 1μg/ml) showed a high dock score (-10.72 kcal/mol) than the remaining inhibitors. Therefore, 
molecular docking using AutoDock suggests the importance of evaluating the prediction accuracy of various molecules as evidenced by a correlation coefficient of 
0.961 between experimental activities and AutoDock binding energies.  
 
 






Dihydrofolate Reductase is a small enzyme that plays a supporting, but an 
essential role, in the building of DNA and other processes. DHFR catalyzes the 
reduction of 7, 8-dihydrofolate (DHF) through stereo-specific hydride transfer 
from reduced nicotinamide-adenine dinucleotide phosphate (NADPH) cofactor. 
The enzyme is essential for tetrahydrofolate (THF) biosynthesis, plays a central 
role in promoting cell growth and proliferation, and is the target of several 
anticancer and antibiotic drugs [1]. Enzymes with essential roles are sensitive 
targets for drug therapy. Dihydrofolate reductase was the first enzyme to be 
targeted for cancer chemotherapy [2]. PfDHFR is a well-characterized target 
for antimalarial antifolate
 drugs, such as pyrimethamine (Pyr) and cycloguanil 
(Cyc). DHFR
 of Plasmodium and other protozoa are expressed on the same 
polypeptide
 chain with its accompanying enzyme, thymidylate synthase (TS). 
TS and DHFR sequentially catalyze
 consecutive reactions in the biosynthesis of 
thymidylate, which
 is required for DNA synthesis [3]. 
 
Malaria, caused by the protozoan parasite Plasmodium falciparum, affects 
about 300  million individuals and causes about 2
 million deaths per year. 
Traditional anti malarial agents
 such as chloroquine are ineffective in many 
regions of the world
  due to drug resistance, chemotherapy targeted at 
dihydrofolate Reductase (DHFR) and thymidylate synthase (TS) has proven to 
be highly effective. Even partial inhibition of DHFR or TS can lead to
 DNA 
strand fragmentation and cell death [4-5]. In malaria pharmacology,
 these two 
enzymes are of particular interest because traditional
  drugs such as 
pyrimethamine and cycloguanil are known to inhibit
  parasite DHFR-TS. In 
recent years, however, the effectiveness
  of these inhibitors has been 
compromised by malarial parasite
 strains expressing mutant forms of DHFR-
TS [6]. One obvious
 way to continue selective killing of malarial parasites is to
 
identify new folate analogs directed at DHFR- or TS-active sites
  that are 
effective against drug-resistant parasites [7].  The folate antagonists are an 
important class of therapeutic compounds, as
 evidenced by their use as anti-
infective, anti neoplastic, and
  anti-inflammatory drugs [8]. Dihydrofolate 
reductase -thymidylate synthase (DHFR-TS) from Plasmodium falciparum is a 
validated target for antifolate antimalarials [9]. Hence, inhibition of DHFR and 
its role in combating malaria has provided us the rationale to carry out structure 
based drug design studies. In this study, compounds synthesized to target 
malaria, from literature, are considered to perform DHFR protein, extracted 
from Protein Data Bank, and ligand interactions using docking software, 
AutoDock. The validation procedures are carried out and the interactions and 
scores are generated. 
 
Materials and Methodology: 
Out of all the entries for DHFR (dihydrofolate reductase) from RCSB protein 
data bank, Plasmodium vivax 2BL9 was taken for docking analysis. The active 
site residues were found to be THR194, ASP53, MET54, PHE57, LEU45, 
SER117, ALA15, ILE13 and ILE173. Protein - ligand docking studies were 
performed to evaluate the algorithm and scoring function efficiency between a 
standalone AutoDock 3.0.5 and experimental activities. The five 2, 4, 6-
trisubstituted triazine inhibitors (active, moderately active and inactive) were 
selected from the article Bioorganic and Medicinal Chemistry Letters 15 2005 BIOINFORMATION  open access 
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531-533 for docking studies. All these molecules as well as the bound ligand of 
the protein 2BL9 were docked by using the software AutoDock and the binding 
affinities were predicted. All molecules are drawn using ISIS draw and energy 
minimized using Tsar Software (www.accelrys.com).  
 
Automated docking was used to locate the appropriate binding orientations and 
conformations of various inhibitors in the 2BL9 binding pocket. To perform the 
task, genetic algorithm routine implemented in the program AutoDock 3.0. was 
employed [10]. All water molecules were removed from the original Protein 
Data Bank file. Polar hydrogen atoms were added and Kolllman charge,
 atomic 
solvation parameters and fragmental volumes were assigned to the protein 
using AutoDock Tools (ADT). To validate the docking protocol, bound ligand 
CP61240 coordinates in the crystal complex was removed and the bond orders 
were checked. For docking calculations, Gasteiger partial charges  were 
assigned to the tested derivatives and CP61240, and non-polar hydrogen atoms 
were merged. All torsions were allowed to rotate during docking.  
 
The program AutoGrid used to generate the grid maps. Each grid was centered 
at the crystal structure of the corresponding 2BL9 bound ligand CP61240. The 
grid dimensions were 60 X 60 X 60 A˚
3 with points separated by 0.375 A˚. 
Lennard-Jones parameters 12-10 and 12-6, supplied with the program, were 
used for modeling H-bonds and van der Waals interactions, respectively. The 
distance-dependent dielectric permittivity of Mehler and Solmajer [11] was 
used for calculation of the electrostatic grid maps. For all ligands, random 
starting positions, random orientations and torsions were used. The translation, 
quaternion and torsion steps were taken from default values in AutoDock. The 
Lamarckian genetic algorithm and the pseudo-Solis and Wets methods were 
applied for minimization using default parameters. The standard docking 
protocol for rigid and flexible ligand docking consisted of 10 independent runs 
per ligand, using an initial population of 50 randomly placed individuals, with 
2.5 X 10
6 energy evaluations, a maximum number of 27000 iterations, a 
mutation rate of 0.02, a crossover rate of 0.80, and an elitism value of 1. The 
probability of performing a local search on an individual in the population was 
0.06, using a maximum of 300 iterations per local search. After docking, the 10 
solutions were clustered into groups with RMS deviations lower than 1.0 Å. 
The clusters were ranked by the lowest energy representative of each cluster.  
 
 
Figure 1: Docked superimposed image of 2BL9 bound ligand CP61240 within 
the binding site region. 
 
Results and Discussion: 
Before docking the ligands (Table 1 see Supplementary material) into the 
2BL9 binding site, the docking protocol was validated. CP61240 bound ligand 
was removed from the active site and docked back into the binding pocket. 
AutoDock predicted binding conformation of CP61240 is shown in Figure 1 
with the X-ray crystallographic obtained conformational superposition [12]. 
The RMSD of all atoms between these two conformations is 0.72 A˚ indicating 
that the parameters for the docking simulation are reasonable in reproducing 
the X-ray crystal structure and can be extended to search the enzyme binding 
conformations for other inhibitors accordingly. The ligands selected for 
docking studies and the corresponding interaction energies are given in Table 
1. The active site of 2BL9 offers many different binding modes for these 
compounds as they are strongly dependent on the attached substituent. This 
observation results from the comparison of ligand binding orientations in the 
active site for known CP61240 and selected compounds. All the ligands were 
docked deeply within the binding pocket region of 2BL9 forming more 
hydrogen bonds with Ile173, Asp53 and Cys14 (Figures 2 and 3). As shown in 
Table 1, their AutoDock binding free energies (ΔGb, kcal/mol) and inhibition 
constants were obtained. Among them compound1 exhibited the lowest free 
energy -7.14 kcal/mol. In other words, it posses the highest potential binding 
affinity into the binding site of 2BL9 protein. The overall good correlation, 
given in Figure-4, between the experimental biological activities and the 
AutoDock binding affinities made a clear representation of utilizing 
computational techniques for drug design. The correlation coefficient of 0.961 
indicates that the correlation was fairly good and demonstrates the applicability 
of the method. 
 
 
Figure 2: Image showing compound 2a interacting residues within the active 
site region of 2BL9 
 
 
Figure 3: Image showing Compound 1 interacting residues within the active 
site region of 2Bl9 
 
Most docked inhibitors interacted in the same fashion as observed with co-
crystallized ligand of 2BL9 protein showing H-bonds with Ile13, Asp53, 
Thr194 and Ile173. The binding modes and geometrical orientation of 
compounds 2a, 2b, 2c, 2l and compound 1 nearly resemble the 2BL9 bound 
ligand CP61240. Moreover, the compound 2a showed two hydrogen bonds 
with Ala15, and the compound 2b showed only one interaction with Cys49 
respectively, where as compound 2c has no  H-bond interactions. Compounds 
2l and 1, showed low binding energy than others, yet the number of hydrogen 
bond interactions are two with Thr194 and Ser117 and four with 
Thr194,Ile13,Asp53 and Ile173, respectively. The most active molecule was BIOINFORMATION  open access 
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found to be 2a and the inactive compound was compound 1. Compound 2a 
exhibited the dock score -10.72 kcal/mol and  it showed two H-bond 
interactions (Figure 2) with active site of 2BL9, one with carbonyl oxygen of 
Ala15 and the other with nitrogen of Ala15. From the Table 1, it became 
evident that there existed a good correlation between experimental activities 
and computational binding energies as obtained with AutoDock. Hence, further 
proof was provided by plotting a graph between experimental values and dock 
scores in Figure 4, where it is clear that they represented a correlation of 0.961. 
 
 
Figure 4: Correlation between experimental and AutoDock binding free 
energies of selected 2, 4, 6-trisubstituted triazine ligands. 
Conclusion: 
AutoDock runs resulted in binding energy scores that range from -7.14 to-
10.72 kcal/mol. Among the five 2, 4, 6-trisubstituted triazine inhibitors selected 
for docking studies, an excellent correlation of 0.96 was observed. Therefore, 
the dock analysis suggests the importance of evaluating the prediction accuracy 
of scoring functions adopted in AutoDock and showed excellent correlation 
between binding free energy (kcal/mol) and IC50 (μM) values against 2BL9 
DHFR protein. Hence, this study demonstrates the importance of drug design 
studies and utility of computational tools in correlating experimental values 
with computational binding energy scores. 
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Table 1: Ligands and their corresponding interaction energies and H-bonding residues 
Compounds  MIC (μg/ml) AutoDock  Binding  Energy  ΔGb (kcal/mol)  No. of H-bonds  Interacting Residues 
2BL9 bound ligand  ---  -7.74 {RMS: 0.72 Aº}  5  ILE13, ILE173, MET53, ASP53, CYS14 
Compound 2a  1  -10.72  2  ALA15 
Compound 2b  2  -9.99  1  CYS49 
Compound 2c  10  -9.53  --  -- 
Compound 2l  50  -7.88  2  THR194, SER117 
Compound 1  64  -7.14  4  THR194, ILE,13, ASP53, ILE173 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  